Aneliya Parvanova

Statistics

Publications

Citations

1.7K

H-Index

Active since

2004

Affiliations

Mario Negri Institute for Pharmacological Research(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

Ospedale Papa Giovanni XXIII

Azienda Ospedaliera Treviglio

Azienda Ospedaliero-Universitaria delle Marche

Aneliya Parvanova is an author at Mario Negri Institute for Pharmacological Research specializing in diabetic nephropathy, medicine, and renal disease.

ORCID

Publications per year

2004–2023

Publications

Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes

Piero Ruggenenti, Esteban Porrini, Flavio Gaspari et al. · Diabetes Care · 2012 · 321 citations · Full text

Medicine, Endocrinology, Nephrology +17

Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial

Nete Tofte, Morten Lindhardt, Katarina Adamova et al. · The Lancet Diabetes & Endocrinology · 2020 · 254 citations · Full text

Medicine, Endocrinology, Nephrology +17

Insulin Resistance and Microalbuminuria

Aneliya Parvanova, Roberto Trevisan, Ilian Iliev et al. · Diabetes · 2006 · 197 citations · Full text

Medicine, Endocrinology, Internal Medicine +10

The GFR and GFR decline cannot be accurately estimated in type 2 diabetics

Flavio Gaspari, Piero Ruggenenti, Esteban Porrini et al. · Kidney International · 2013 · 151 citations

Medicine, Endocrinology, Internal Medicine +4

Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus

Piero Ruggenenti, Giuseppe Lauria, Ilian Iliev et al. · Hypertension · 2011 · 101 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

1–5 of 22